Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
February 27, 2008
from PR Newswire
Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
February 27, 2008
from PR Newswire
Mylan Announces Appointment of Jagdish Dore' as CEO and Managing Director of Matrix Laboratories
February 27, 2008
from PR Newswire
Mylan Announces Appointment of Patrick Vink as Senior Vice President in New Position of Global Head of Biologics
February 26, 2008
from PR Newswire
Mylan Announces Appointment of Eric M. Leeds as Senior Vice President and Head of Global Investor Relations
February 25, 2008
from PR Newswire
Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
February 21, 2008
from PR Newswire
Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
February 14, 2008
from PR Newswire
Mylan Restores Availability of Generic Levothyroxine in Florida
February 08, 2008
from PR Newswire
Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007
February 05, 2008
from PR Newswire
Mylan Announces Final FDA Approval for Granisetron Hydrochloride Tablets
February 01, 2008
from PR Newswire
Mylan Declares Quarterly Preferred Stock Dividend
January 30, 2008
from PR Newswire
from PR Newswire
Dey, L.P. Settles State of Alabama Pricing Litigation
January 09, 2008
from PR Newswire
Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules
December 31, 2007
from PR Newswire
Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets
December 28, 2007
from PR Newswire
Mylan Sets Date of 2008 Annual Meeting
December 21, 2007
from PR Newswire
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
December 18, 2007
from PR Newswire
/C O R R E C T I O N -- Mylan Inc./
December 12, 2007
from PR Newswire
Mylan Announces Tentative FDA Approval for Lamotrigine Tablets
December 12, 2007
from PR Newswire
Mylan Receives $26.2 Million From Exercise of Overallotment Option of Common Stock
December 06, 2007
from PR Newswire
Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
December 04, 2007
from PR Newswire
from PR Newswire
Dey, L.P. Partners with COPD Foundation in Support of National Heart, Lung and Blood Institute (NHLBI)'s COPD Learn More Breathe Better Awareness Campaign
November 28, 2007
- Government-advocacy-industry collaboration is national program to raise awareness of emphysema and chronic bronchitis (COPD) - Read More
from PR Newswire
Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations
November 26, 2007
from PR Newswire
Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock
November 19, 2007
from PR Newswire
from PR Newswire
Mylan Launches Registered Offering of Common Stock and Mandatory Convertible Preferred Stock
November 01, 2007
from PR Newswire
Mylan Reports Adjusted Diluted Cash EPS of $0.31
November 01, 2007
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here